Skip to main content
Clinical Trials/NCT00739843
NCT00739843
Terminated
N/A

Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients

University of Chicago1 site in 1 country55 target enrollmentNovember 2007

Overview

Phase
N/A
Intervention
Not specified
Conditions
Dementia
Sponsor
University of Chicago
Enrollment
55
Locations
1
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to estimate how quickly cognitive status and functional status in older patients on hemodialysis declines.

Detailed Description

Dialysis outcome measures, which predict morbidity and mortality of younger patients on renal replacement therapy, such as dialysis clearance, do not correlate with survival of the elderly patients on hemodialysis. Survival of older patients on hemodialysis is significantly worse when compared to that of the younger patients. Conditions commonly affecting older adults, such as functional decline, cognitive impairment, depression and declining quality of life have not been well studied in hemodialysis population. There may be an important relationship between these measurements and outcomes in older dialysis patients. Institution of appropriate age-specific interventions could result in improved health status and mortality of older patients on hemodialysis. Our broad objective is to better understand global functioning of the elderly dialysis patients and its possible impact on dialysis outcomes in attempt to improve health care of the older patients receiving hemodialysis.

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
September 2010
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Prevalent and incident hemodialysis patients over the age of 60, receiving hemodialysis treatments at the University of Chicago outpatient dialysis program.

Exclusion Criteria

  • Patients 59 and younger, and patients with the following medical conditions: malignancies currently requiring chemotherapy or radiation therapy, severe heart failure (NYHA class IV), known HIV infection, or currently active hepatic encephalopathy.

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials